摘要
目的研究分析冠心病心绞痛内科治疗中应用不同药物所产生的临床疗效。方法抽取我院60例冠心病心绞痛患者,随机分为观察组与对照组,对照组使用磷酸酯类、阿司匹林、消心痛等进行常规内科治疗,观察组在此基础上加用曲美他嗪进行治疗。结果观察组治疗总有效率明显高于对照组,治疗后心绞痛发作频率、持续时间及硝酸甘油用量均明显少于对照组,差异有统计学意义(P﹤0.05)。结论在对冠心病心绞痛患者的内科治疗中加用曲美他嗪,能够更为有效的减少心绞痛的发作频率及持续时间,明显提高临床治疗效果。
Objective To analyze the clinical effects of different medications in the medical treatment of angina pectoris. Methods Sixty patients with angina pectoris selected from our hospital were randomly divided into observation group and control group. Both groups received conventional medical treatment with phosphate, aspirin, and isosorbide dinitrate, and the observation group received trimetazidine as an addition. Results Compared with the control group, the observation group had a significantly increased overall response rate and significantly decreased frequency and duration of angina pectoris and consumption of nitroglycerin after treatment （P〈0.05）. Conclusion Additional use of trimetazidine in medical treatment can further decrease the frequency and duration of angina pectoris in patients with angina pectoris, thus significantly improving the treatment outcome.
出处
《心血管病防治知识（学术版）》
2013年第5期40-42,共3页
Prevention and Treatment of Cardiovascular Disease
